Merck
MRK
#39
Rank
NZ$647.85 B
Marketcap
NZ$262.79
Share price
-0.14%
Change (1 day)
70.45%
Change (1 year)

EPS for Merck (MRK)

EPS in 2023 (TTM): NZ$2.94

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$1.78. In 2022 the company made an earnings per share (EPS) of NZ$10.26 an increase over its 2021 EPS that were of NZ$9.25.

EPS history for Merck from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$2.94-71.38%
2022NZ$10.2610.92%
2021NZ$9.2584.68%
2020NZ$5.01-27.2%
2019NZ$6.8863.44%
2018NZ$4.21151.11%
2017NZ$1.68-54.58%
2016NZ$3.6930.21%
2015NZ$2.83-61.99%
2014NZ$7.46180.51%
2013NZ$2.66-31.82%
2012NZ$3.906.62%
2011NZ$3.66626.78%
2010NZ$0.50-95.05%
2009NZ$10.1756.36%
2008NZ$6.50-449.04%
2007NZ-$1.86-150.98%
2006NZ$3.65-3.32%
2005NZ$3.78-20.08%
2004NZ$4.73-10.81%
2003NZ$5.30-6.92%
2002NZ$5.700%
2001NZ$5.707.43%
2000NZ$5.3017.93%
1999NZ$4.5013.06%
1998NZ$3.9815.63%
1997NZ$3.4420%
1996NZ$2.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.97 573.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.40 428.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36-23.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.84 172.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.28 3,009.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$29.05 1,533.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.41 91.69%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.10 355.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.15 189.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.13-36.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel